...
search icon
flna-img

Filana Therapeutics, Inc. Share Price

FLNA
NAQ
$1.73
-$0.03
(-1.7%)
1D

Filana Therapeutics, Inc. Analyst Forecast

Filana Therapeutics, Inc. Share Price Chart

Filana Therapeutics, Inc. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$85.02M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
463.06K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.68
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.37 L
$4.98 H
$1.73

About Filana Therapeutics, Inc., Common Stock

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas. more

Filana Therapeutics, Inc. Stock Returns

Data is not properly formatted.

Filana Therapeutics, Inc. Financials

Dec '21Dec '22Dec '23Dec '24Dec '255YR TREND
Total Revenue-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Cost of Revenue----936.00K[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Gross Profit----(936.00K)[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":-93600000,"profit":false}]
Gross Margin-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Operating Expenses32.87M80.02M105.96M141.45M94.45M[{"date":"2021-12-31","value":23.24,"profit":true},{"date":"2022-12-31","value":56.57,"profit":true},{"date":"2023-12-31","value":74.91,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":66.78,"profit":true}]
Operating Income(32.87M)(80.02M)(105.96M)(141.45M)(95.39M)[{"date":"2021-12-31","value":-3286800000,"profit":false},{"date":"2022-12-31","value":-8002000000,"profit":false},{"date":"2023-12-31","value":-10595700000,"profit":false},{"date":"2024-12-31","value":-14144600000,"profit":false},{"date":"2025-12-31","value":-9539000000,"profit":false}]
Total Non-Operating Income/Expense-6.55M16.57M125.61M9.04M[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":5.22,"profit":true},{"date":"2023-12-31","value":13.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":7.19,"profit":true}]
Pre-Tax Income(32.38M)(76.25M)(97.22M)(24.34M)(90.97M)[{"date":"2021-12-31","value":-3238500000,"profit":false},{"date":"2022-12-31","value":-7624600000,"profit":false},{"date":"2023-12-31","value":-9721700000,"profit":false},{"date":"2024-12-31","value":-2434200000,"profit":false},{"date":"2025-12-31","value":-9097300000,"profit":false}]
Income Taxes-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Income From Continuous Operations-(76.25M)(97.22M)(24.34M)(90.97M)[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-7624600000,"profit":false},{"date":"2023-12-31","value":-9721700000,"profit":false},{"date":"2024-12-31","value":-2434200000,"profit":false},{"date":"2025-12-31","value":-9097300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income(32.38M)(76.25M)(97.22M)(24.34M)(90.97M)[{"date":"2021-12-31","value":-3238500000,"profit":false},{"date":"2022-12-31","value":-7624600000,"profit":false},{"date":"2023-12-31","value":-9721700000,"profit":false},{"date":"2024-12-31","value":-2434200000,"profit":false},{"date":"2025-12-31","value":-9097300000,"profit":false}]
EPS (Diluted)(0.82)(1.90)(2.32)(1.45)(1.88)[{"date":"2021-12-31","value":-81.58,"profit":false},{"date":"2022-12-31","value":-189.67,"profit":false},{"date":"2023-12-31","value":-231.92,"profit":false},{"date":"2024-12-31","value":-144.81,"profit":false},{"date":"2025-12-31","value":-188.04,"profit":false}]

Filana Therapeutics, Inc. Ratios

Filana Therapeutics, Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

FLNA
Cash Ratio 2.18
Current Ratio 2.23

Filana Therapeutics, Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

FLNA
ROA (LTM) -27.23%
ROE (LTM) -82.66%

Filana Therapeutics, Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

FLNA
Debt Ratio Lower is generally better. Negative is bad. 0.37
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.63

Filana Therapeutics, Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

FLNA
Trailing PE NM
Forward PE 151.52
P/S (TTM) 2.54
P/B 1.05
Price/FCF NM
EV/R 1.33
EV/Ebitda 2.08
PEG 1.62

FAQs

What is Filana Therapeutics, Inc. share price today?

Filana Therapeutics, Inc. (FLNA) share price today is $1.73

Can Indians buy Filana Therapeutics, Inc. shares?

Yes, Indians can buy shares of Filana Therapeutics, Inc. (FLNA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in FLNA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Filana Therapeutics, Inc. be purchased?

Yes, you can purchase fractional shares of Filana Therapeutics, Inc. (FLNA) via the Vested app. You can start investing in Filana Therapeutics, Inc. (FLNA) with a minimum investment of $1.

How to invest in Filana Therapeutics, Inc. shares from India?

You can invest in shares of Filana Therapeutics, Inc. (FLNA) via Vested in three simple steps:

  • Click on Sign Up or Invest in FLNA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Filana Therapeutics, Inc. shares
What is Filana Therapeutics, Inc. 52-week high and low stock price?

The 52-week high price of Filana Therapeutics, Inc. (FLNA) is $4.98. The 52-week low price of Filana Therapeutics, Inc. (FLNA) is $1.37.

What is Filana Therapeutics, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Filana Therapeutics, Inc. (FLNA) is

What is Filana Therapeutics, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Filana Therapeutics, Inc. (FLNA) is 1.05

What is Filana Therapeutics, Inc. dividend yield?

The dividend yield of Filana Therapeutics, Inc. (FLNA) is 0.00%

What is the Market Cap of Filana Therapeutics, Inc.?

The market capitalization of Filana Therapeutics, Inc. (FLNA) is $85.02M

What is Filana Therapeutics, Inc.'s stock symbol?

The stock symbol (or ticker) of Filana Therapeutics, Inc. is FLNA

How Can Investors Use Filana Therapeutics, Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Filana Therapeutics, Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Filana Therapeutics, Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Filana Therapeutics, Inc. shares for Indian investors?

When investing in Filana Therapeutics, Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Filana Therapeutics, Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Filana Therapeutics, Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of Filana Therapeutics, Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Filana Therapeutics, Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top